Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

BMT for severe aplastic anemia using cyclosporine

W S May1, L L Sensenbrenner, W H Burns

  • 1Bone Marrow Transplant Service, Johns Hopkins Oncology Center, Johns Hopkins University School of Medicine, Baltimore, MD 21231.

Bone Marrow Transplantation
|June 1, 1993
PubMed
Summary

Hematopoietic stem cell transplantation (HSCT) using HLA-identical sibling bone marrow (BM) offers high survival for severe aplastic anemia (SAA). Further research is needed to address graft instability post-transplant.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Professional Remuneration.

The Georgia medical companion·2022
Same author

Coastal sedimentation across North America doubled in the 20<sup>th</sup> century despite river dams.

Nature communications·2020
Same author

Efficacy of digital cognitive behavioural therapy for symptoms of generalised anxiety disorder: a study protocol for a randomised controlled trial.

Trials·2020
Same author

Sleep interventions for osteoarthritis and spinal pain: a systematic review and meta-analysis of randomized controlled trials.

Osteoarthritis and cartilage·2018
Same author

Typhoid Fever Presenting Some Unusual Features.

The Indian medical gazette·2017
Same author

Determinants and Trends of Gynecologic Minimally Invasive Surgery in Developing Countries.

Journal of minimally invasive gynecology·2016

Area of Science:

  • Hematology
  • Immunology
  • Transplantation Medicine

Background:

  • Severe aplastic anemia (SAA) is a life-threatening condition.
  • Hematopoietic stem cell transplantation (HSCT) is a potential curative therapy.
  • Previous HSCT protocols had variable outcomes.

Purpose of the Study:

  • To evaluate the efficacy and safety of HSCT for SAA.
  • To assess long-term survival and complications.
  • To identify areas for improvement in HSCT protocols.

Main Methods:

  • Retrospective analysis of 24 SAA patients undergoing HSCT.
  • HLA-identical sibling donor bone marrow (BM) transplantation.
  • Conditioning with cyclophosphamide (CY) and post-transplant immunosuppression with cyclosporine (CYA).

Related Experiment Videos

Main Results:

  • Overall long-term survival was 79%.
  • Graft failure occurred in 2 patients (primary engraftment failure) and 5 patients (secondary graft instability).
  • Low incidence of acute and no chronic graft-versus-host disease (GVHD).

Conclusions:

  • HSCT with CY conditioning and CYA immunosuppression is well-tolerated with excellent survival for SAA.
  • High rates of graft instability warrant further investigation into post-transplant immunomodulation strategies.